Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma
Astrid Murumägi(University of Helsinki), Olli Kallioniemi(University of Helsinki)
Cited by 25
Related Papers
Identification of fusion genes in breast cancer by paired-end RNA-sequencing
|Genome biology|2011|328
Association of tamoxifen resistance and lipid reprogramming in breast cancer
|BMC Cancer|2018|217